Note: This document contains side effect information about clobetasol topical. Some of the dosage forms listed on this page may not apply to the brand name Temovate.
Applies to clobetasol topical: topical application cream, topical application emollient cream, topical application foam, topical application gel/jelly, topical application lotion, topical application ointment, topical application shampoo, topical application solution, topical application spray
Along with its needed effects, clobetasol topical (the active ingredient contained in Temovate) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking clobetasol topical:
Incidence not known
Some side effects of clobetasol topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
Applies to clobetasol topical: compounding powder, topical cream, topical foam, topical gel, topical kit, topical lotion, topical ointment, topical shampoo, topical solution, topical spray
The most common side effect reported was skin discomfort.
Postmarketing reports: Cushing's syndrome, adrenal suppression
Common (1% to 10%): Skin discomfort, acne/folliculitis, telangiectasia, skin atrophy, dry skin
Uncommon (0.1% to 1%): Local signs of irritation, pruritus, urticaria
Frequency not reported: Stria, purpura, contact dermatitis, pigmentation changes, pustular eruptions, hypertrichosis, irritant dermatitis
Postmarketing reports: Erythema, alopecia, pain of skin, skin exfoliation, chapped skin, scaling, induration/papulation,
lichenification, psoriasis (aggravation) plaque elevation, excoriation, rash, hair color changes, skin tightness
Frequency not reported: Itching
Common (1% to 10%): Eye stinging/burning
Postmarketing reports: Eye pain, blurred vision, eye irritation
Frequency not reported: Edema
Postmarketing reports: Nausea
Frequency not reported: Hyperglycemia, glucosuria
Common (1% to 10%): Headache
Postmarketing reports: Dizziness
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Temovate E